Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Advanced Cancer × Palliative Care × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 10 Leukemia, Myeloid, Acute 7 Neoplasms 6 Ovarian Neoplasms 4 Lung Neoplasms 4 Pancreatic Neoplasms 3 Glioblastoma 3 Fatigue 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Vulvar Neoplasms 2 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Sarcoma 2 Peritoneal Neoplasms 2 Multiple Myeloma 2 Melanoma 2 Lymphoma 2 Leukemia 2 Hematologic Neoplasms 2 Glioma 2 Genital Neoplasms, Female 2 Esophageal Neoplasms 2 Weight Loss 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Urinary Bladder Neoplasms 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1

Interventions

Nivolumab 10 Surveys and Questionnaires 6 Bevacizumab 5 linrodostat 4 Standard of Care 4 Ipilimumab 4 Interviews as Topic 4 Docetaxel 4 temsirolimus 3 Sirolimus 3 Pemetrexed 3 Paclitaxel 3 Gemcitabine 3 Erlotinib Hydrochloride 3 Cetuximab 3 ARRY-334543 3 relatlimab 2 regorafenib 2 abemaciclib 2 Vorinostat 2 Trastuzumab 2 Sorafenib 2 N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide 2 Magnetic Resonance Spectroscopy 2 Carboplatin 2 vorolanib 1 vistusertib 1 trametinib 1 tislelizumab 1 sargramostim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01444157 2014-07-18

FamCope

Bispebjerg Hospital

Phase 3 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡